TITLE

Animal Tester

AUTHOR(S)
Pocha, Jehangir S.
PUB. DATE
October 2006
SOURCE
Forbes Asia;10/30/2006, Vol. 2 Issue 18, p24
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on the ability of Bridge Pharmaceuticals Corp. to help U.S. pharmaceutical companies outsource laboratory work to China in 2006. Bridge Pharmaceuticals, which is headed by CEO Glenn Rice, is a contract research organization in San Francisco Bay Area, California. According to Rice, outsourcing research to China will have an impact on people suffering from uncommon and orphan diseases.
ACCESSION #
23061403

 

Related Articles

  • R&D Outsourcing That Works. Malek, Jan // Pharmaceutical Executive;Mar2000, Vol. 20 Issue 3, p70 

    Provides a framework that will enable pharmaceutical companies and contract research organizations to create stronger outsourcing relationship. Themes of dissatisfaction among companies; Importance of understanding the evolution of research and development outsourcing; Characteristics of...

  • Three Challenges. Nicholas, Judith A.; Squires, Douglas J.; Lennox, R. Ian // Pharmaceutical Executive;Jun2002 Supplement, Vol. 23, p96 

    Presents the challenges facing contract research organizations (CRO). Increase in outsourcing since 1997; Information on how CRO can help increase productivity; Strategies needed by CRO to help customers adapt and profit from changes.

  • Pharm It Out.  // Pharmaceutical Executive;Apr2005, Vol. 25 Issue 4, p32 

    Reports on the practice of outsourcing manufacturing and research among pharmaceutical industry in the U.S. Growth rate of the contract manufacturing of over-the-counter drugs; Increase in the demand for pharmaceuticals; Implementation of cost-cutting initiatives.

  • Outsourcing Winners in 2014. Langer, Eric // Pharmaceutical Technology;Nov2010, Vol. 34 Issue 11, p112 

    The article focuses on the outsourcing in the biopharmaceutical industry in China and India which is considered as a strategic safety valve by some companies. It states that start-up contract manufacturing organizations in China are not growing as aggressively as predicted prior to the...

  • Pharmaceutical Analytical Testing. Coker, Victor // Pharmaceutical Processing;Nov2011, Vol. 26 Issue 10, p22 

    The article discusses the issues concerning contract research organization (CRO) and contract manufacturing organization (CMO) in the pharmaceutical industries in the U.S. It mentions that contract manufacturers and researchers are increasingly adopting to global regulatory standards, which will...

  • Riding the R&D recession wave. Brooks, Kristin // Contract Pharma;Jun2010, Vol. 12 Issue 5, p56 

    The article focuses on the effect of the recession to Contract Research Organizations (CROs) of pharmaceutical industry. It states that the recession encourage the pharmaceutical industry to outsource more. CROs play major role in providing its sponsors with outsourcing and drug development...

  • Specialist CROs Aid Pharmas With Better R&D Efficiency. Gwynne, Peter // Drug Discovery & Development;Oct2002, Vol. 5 Issue 9, p81 

    Focuses on the use of preclinical outsourcing specialty by pharmaceutical and biotechnology companies to increase research and development efficiency and rationalize commercialization expenses. Role of contract research organizations in performing clinical services for pharmaceutical companies;...

  • Pharma Outsourcing to Grow Seven-fold. Bajaj, Kapil // Business Today;5/20/2007, Vol. 16 Issue 10, p26 

    The article examines the status of pharmaceutical outsourcing in India. The country's contract research and manufacturing services (CRAMS) market was valued at $895.44 million in 2006. CRAMS had been contributing close to eight percent to the pharmaceutical industry's revenues. It comprised...

  • Debottlenecking R&D. Schmitt, Bill; Hume, Claudia // Chemical Week;1/31/2001, Vol. 163 Issue 5, p30 

    Focuses on research and development activities in the chemical industry. Names of several companies providing genomic services; Why outsourcing is growing; Impact on the fine chemical industry of the decreased reluctance of drug companies to farm out active pharmaceutical ingredient...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics